The role of linkage studies for common diseases

Current Opinion in Genetics and Development

Volumn 11, Issue 3, 2001, Pages 264-267

  Gulcher, Jeffrey R ^a   Kong, Augustine ^a   Stefansson, Kari ^a  

^a DECODE GENETICS   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; GENE MAPPING; GENEALOGY; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; ICELAND; PARKINSON DISEASE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIBLING; STROKE;

CASE-CONTROL STUDIES; DISEASE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; LINKAGE (GENETICS); PEDIGREE;

EID: 0035370203     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00188-X     Document Type: Review

References (26)

1. Risch N. Searching for genetic determinants in the new millennium. Nature. 405:2000;847-856. The author summarizes the historical difficulties of the linkage approach for common diseases, and suggests both reasons for the difficulties and alternative approaches.
2. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 11:1995;241-247.
3. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
4. Altshuler D., Hirschhorn J.N., Klannemark M., Lindgren C.M., Vohl M.C., Nemesh J., Lane C.R., Schaffner S.F., Bolk S., Brewer C., Tuomi T., et al. The common PPAR-γ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 26:2000;76-80. This is a recent example of a large case-control study of a candidate gene for non-insulin-dependent diabetes mellitus where the authors demonstrate statistically significant association of the disease to a very common SNP of small effect.
5. Weeks D.E., Lange K. The affected-pedigree-member method of linkage analysis. Am J Hum Genet. 42:1988;315-326.
6. Whittemore A.S., Halpern J. A class of tests for linkage using affected pedigree members. Biometrics. 50:1994;118-127.
7. Kruglyak L., Daly M.J., Reeve-Daly M.P., Lander E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. AmJ Hum Genet. 1179:1996;1347-1363.
8. Kong A., Cox N.J. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet. 61:1997;1179-1188.
9. Roses A.D. Pharmacogenomics and the practice of medicine. Nature. 405:2000;857-866. The author provides a comprehensive review of the proposed use of SNPs in case-control studies of pharmacogenomic traits, and looks at the future of SNP profiling in predicting drug response.
10. Collins F.S., Guyer M.S., Chakravarti A. Variations on a theme: cataloging human DNA sequence variation. Science. 278:1997;1580-1581.
11. Kruglyak L. Prospects for whole-genome linkage disequilibrium mapping of common disease genes. Nat Genet. 22:1999;139-144. The author carries out systematic simulations to predict the power of case-control genetic studies that use SNPs and assume a variety of models of common disease. He also relates the power of this approach to number of SNP markers used in the genome-wide scan and predicts that more isolated populations may not have an advantage for such approaches.
12. Arheim N., Strange C., Erlich H. Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc Natl Acad Sci USA. 82:1985;6970-6974.
13. Muller-Myhsok B., Abel L. Genetic analysis of complex diseases. Science. 275:1997;1328-1329.
14. Tu I.P., Whittemore A.S. Power of association and linkage tests when the disease alleles are unobserved. Am J Hum Genet. 64:1999;641-649.
15. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 52:1993;506-516.
16. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 46:1990;229-241.
17. Gulcher J.R., Stefansson K. Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med. 36:1998;523-527.
18. Helgason A., Sigurethardottir S., Gulcher J.R., Ward R., Stefansson K. mtDNA and the origin of the Icelanders: deciphering signals of recent population history. Am J Hum Genet. 66:2000;999-1016.
19. Sigurgardottir S., Helgason A., Gulcher J.R., Stefansson K., Donnelly P. The mutation rate in the human mtDNA control region. Am J Hum Genet. 66:2000;1599-1609.
20. World Health Organization http://www.who.org.
21. Protection of privacy at deCODE genetics http://www.decode.is/ppt/protection/index.htm.
22. Gulcher J.R., Kristjansson K., Gudbjartsson H., Stefansson K. Protection of privacy by third-party encryption in genetic research in Iceland. Eur J Human Genetics. 8:2000;739-742.
23. Gudbjartsson D.F., Jonasson K., Frigge M.L., Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat Genet. 25:2000;12-13. The authors describe the Allegro program and how to obtain this program free for non-commercial use.
24. Ott J. Analysis of Human Linkage. edn 3:1999;The Johns Hopkins University Press, Baltimore and London.
25. Tanner C.M., Ottman R., Goldman S.M., Ellenberg J., Chan P., Mayeux R., Langston J.W. Parkinson disease in twins: an etiologic study. J Am Med Assoc. 281:1999;341-346.
26. Sveinbjornsdottir S., Hicks A.A., Jonsson T., Petursson H., Guomundsson G., Frigge M.L., Kong A., Gulcher J.R., Stefansson K. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med. 343:2000;1765-1770.